免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

MIRARI® 冷等离子体系统 (GV-M2-01)

K号: K242553 · 2024-11-21

决定日期2024-11-21
产品代码PBX
咨询委员会SU 请注意,您提供的文本“SU”不足以进行翻译。请提供完整的描述性文本以便进行翻译。
决定实质等同

器械摘要

MIRARI® Cold Plasma System ( GV-M2-01) is the device name listed in this FDA 510(k) record. The listed applicant is General Vibronics, Inc.. It received FDA 510(k) clearance on 2024-11-21 under 510(k) number K242553. The device is classified under product code PBX. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the MIRARI® Cold Plasma System ( GV-M2-01)?

MIRARI® Cold Plasma System ( GV-M2-01) is a medical device that received FDA 510(k) clearance on 2024-11-21. The listed applicant is General Vibronics, Inc.. The 510(k) number is K242553.

When did MIRARI® Cold Plasma System ( GV-M2-01) receive FDA 510(k) clearance?

MIRARI® Cold Plasma System ( GV-M2-01) received FDA 510(k) clearance on 2024-11-21, under 510(k) number K242553.

Who is the listed applicant for MIRARI® Cold Plasma System ( GV-M2-01)?

The FDA 510(k) record lists General Vibronics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MIRARI® Cold Plasma System ( GV-M2-01)?

The FDA product code for MIRARI® Cold Plasma System ( GV-M2-01) is PBX.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:PBX)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑